Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

Clinical trial NCT06939036 · TERMINATED

Trial details

NCT number: NCT06939036
Sponsor: Ariceum Therapeutics GmbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage Merkel Cell Carcinoma

Start date: 2025-07-01
Primary completion: 2025-12-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.